The MMR vaccine controversy - Winners, losers, impact and challenges

British Journal of Infection Control

Volumn 8, Issue 1, 2007, Pages 18-22

  MacDonald, Pauline F ^a  

^a Dudley Primary Care Trust   (United Kingdom)

Author keywords

Controversy; Immunisation; Measles; MMR; Mumps; Rubella

Indexed keywords

EID: 33847790161     PISSN: 14690446     EISSN: None     Source Type: Journal    
DOI: 10.1177/14690446070080010901     Document Type: Article

References (56)

1. Afzal MA, Minor PD, Begle J, Bentley MC, Armitage E, Ghoah S, Ferguson A. (1998) Absence of measles-virus genome in inflammatory bowel disease. The Lancet 351(9103): 646-7.
2. Ashraf H. (2001) US expert group rejects link between MMR and autism. The Lancet 357(9245): 1341.
3. Bedford H, Booy R, Dunn D. DiGuiseppi C, Gibb D, Gilbert R, Logan S, Peckham C, Roberts I, Tookey P. (1998). Autism, inflammatory bowel disease and MMR vaccine. The Lancet 351(9106): 907.
4. Beard M. (2001) Consultant who linked MMR jab to autism quits after 'political pressure'. See: http://news.independent.co.uk/uk/ health⋯dical/article147068.ece (accessed 25 May 2006).
5. Black C, Kaye J A, Jick H. (2002). Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. British Medical Journal 325: 419-21.
6. Burgess DC, Burgess MA, Leask J. (2006). The MMR vaccination and autism controversy in United Kingdom 1998-2005: Inevitable community outrage or a failure of risk communication? Vaccine 24: 3921-8.
7. Casiday R, Cresswell T, Wilson D, Panter-Black C. (2006). A survey of parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 24: 177-84.
8. Chadwick N, Bruce I J, Schepelman S, Pounder RE, Wakefield AJ. (1998). Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by polymerase chain reaction. Journal of Medical Virology 70: 305-11.
9. Chen W, Landau S, Sham P, Fombonne E. (2004) No evidence for links between autism, MMR and measles virus. Psychological Medicine 34(3): 543-53.
10. Deer B. (2005) MMR scare doctor faces list of charges. See: www.timesonline.co.uk/article/o,,8122-1774388,00.htlm (accessed 4 July 2006).
11. Demicheli V, Jefferson T, Rivetti A, Price D. (2005). Vaccines for measles, mumps and rubella in children. The Cochrane Database of Systematic Reviews 4: Article No: CD004407 pub2. DOI:10.1002/ 14651858.CD004407.pub2.
12. Department of Health. (2006) Choice matters: increasing choice improves patients' experiences. HMSO: London.
13. Farrington CP, Miller E, Taylor B. (2001) MMR and autism: further evidence against a causal association. Vaccine 19(27): 3632-5.
14. Fisher BL. (1998) Autism, inflammatory bowel disease and MMR vaccine. The Lancet 351(9112): 1357-8.
15. General Medical Council. (2003) Target payments for preventative health measures. See: www.gmc-uk.org/guidance/library/ targeting_preventative_mesures.asp (accessed 12 July 2006).
16. Health Protection Agency. (2006) Laboratory confirmed cases of measles, mumps and rubella, in England and Wales: January to March 2006. Communicable Disease Report Weekly 16(25): 7.
17. Health Protection Agency. (2006a) Measles notifications and deaths in England and Wales: 1940-2004 See: www.hpa.org.uk/infections/topics_az/ measles/nots_and_deaths.htm accessed 3 July 2006).
18. Hodgson H. (2004) A statement by The Royal Free and University College Medical School and The Royal Free Hampstead NHS Trust. The Lancet 363(9411): 824.
19. Honda H, Shimizu Y, Rutter M. (2005) No effect of MMR with drawal on the incidence of autism: a total population study. Journal of Child Psychology and Psychiatry 46(6): 572-9.
20. Horton R. (1998) Autism, inflammatory bowel disease and MMR vaccine. The Lancet 351(9106): 909.
21. Horton R. (2004) The lessons of MMR. The Lancet 363(9411): 747-9.
22. Horton R. (2004a). A statement by the editors of The Lancet. The Lancet 363(9411): 820-1.
23. JABS. (2006). The UK MMR vaccination briefing note: April 2006. See: www.jabs.org.uk/pages/information.htm (accessed 4 July 2006).
24. Jefferson T, Price D, Demicheli V, Bianco E. (2003). Unintended events following immunization with MMR: a systematic review. Vaccine 21: 3954-60.
25. Kaye J, del Mar Melero-Montes M, Jick H. (2001) Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. British Medical Journal 322: 460-3.
26. Lee JW, Melgaard B, Clements CJ, Kane M, Mulholland EK, Olive J-M. (1998). Autism, inflammatory bowel disease and MMR vaccine. The Lancet 351(9106): 905.
27. Legal Services Commission. (2003) Decision to remove funding for MMR litigation upheld on appeal. See: www.mmrthefacts.nhs.uk/news/ newsitem.php?id=59 (accessed 4 July 2006).
28. Lewin J, Dhillon AP, Sim R, Mazure G, Pounder RE, Wakefield AJ. (1995) Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gul 36(4): 564-9.
29. Lindley KJ, Milla PJ. (1998) Autism, inflammatory bowel disease and MMR vaccine. The Lancet 351(9106): 907.
30. Lyall S. (2002) Britain tries to quell fear over vaccine for children. The New York Times: 11 February.
31. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Mellbye M. (2002) A population-based study of measles, mumps and rubella vaccination and autism. New England Journal of Medicine 347(19): 1477-82.
32. Mäkelä A, Nuorti J P, Peltola H. (2002) Neurological disorders after measles-mumps-rubella vaccination. Pediatrics 110(5): 957-63.
33. Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. (1999). Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 116(4): 796-803.
34. Miller C. (2004) The MMR debate: probability and relative risk. New Law Journal 154(7119): 365.
35. Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Valentine A, Davies SE and Walker-Smith JA, (2004) Retraction of an interpretation. The Lancet 363(9411): 750.
36. NHS. (2006) Immunisation: why our children must be protected. See: www.mmrthefacts.nhs.uk/news/newsitem.php?id=109 (accessed 20 July 2006).
37. O'Dell L, Brownlow C. (2005) Media reports and links between MMR and autism: a discourse analysis. British Journal of Learning Disabilities 33: 194-9.
38. Offit PA, Coffin SE. (2003) Communicating science to the public: MMR vaccine and autism. Vaccine 22: 1-6.
39. Passwell JH. (1999) MMR vaccination, Crohn's disease and autism: a real or imagined 'stomach ache/headache?'. Israel Medical Association Journal 1: 176-7.
40. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. (1998) No evidence for measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14-year prospective study (research letters). The Lancet 351(9112): 1327-8.
41. Poltorak M, Leach M, Fairhead J, Cassell J. (2005) 'MMR talk' and vaccination choices: an ethnographic study in Brighton. Social Science and Medicine 61: 709-19.
42. Ramsay S. (2002) UK government tries to control MMR panic. The Lancet 359(9306): 590.
43. Robins J. (2003) 'Why have they let us down?' The Independent 23 September 2003: 12. See: http://news.independent.co.uk/uk/legal/ article88150.ece (accessed 14 July 2006).
44. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, Hall AJ. (2004) MMR vaccination and pervasive developmental disorders: a case-control study. The Lancet 364(9438): 963-9.
45. Smith GCS, Pell JP. (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. British Medical Journal 327: 1459-61.
46. Stroud L. (2005) MMR - public policy in crisis: whose tragedy? Journal of Health Organisation and Management 19(3): 252-9.
47. Takahashi H, Suzumura S, Shriakizawa F, Wada N, Tanaka-Taya K, Arai S, Okabe N, Ichikawa H, Sato T. (2003) An epidemiological study on Japanese autism concerning routine childhood immunization history. Japanese Journal of Infectious Diseases 56: 114-7.
48. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. (2002) Measles, mumps and rubella vaccination and bowel problems or development regression in children with autism: population study. British Medical Journal 324: 393-6.
49. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB, Walker-Smith J, Thomson M, Wakefield AJ and O'Leary JJ. (2002) Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Journal of Clinical Pathology Molecular Pathology 55: 84-90.
50. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M. Berelowitz M, Dillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. (1998) Ileal-lymphoid-nodu lar hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet 351(9103): 637-41.
51. Wakefield AJ, Anthony A, Schepelmann S. Murch SH, Montgomery SM, Walker-Smith JA. (1998) Persistent measles virus infection and immunodeficiency in children with autism, ileo-colonic lymphoid nodular hyperplasia and non-specific colitis. Gut 42 (Supplement 1): A86.
52. Wakefield AJ. (2004) A statement by Dr Andrew Wakefield. The Lancet 363(9411): 823-4.
53. Wakefield AJ, Harvey P, Linnell J. (2004) MMR - responding to retraction. The Lancet 363: 1327-8.
54. What Doctor's Don't Tell You. (2006) MMR and autism: oh deer. E-News Broadcast: 15 June 2006. See: www.wddty.co.uk (accessed 15 June 2006).
55. Wilson K, Mills E, Ross C, McGowan J, Jadad A. (2003). Association of autistic spectrum disorder and the measles, mumps and rubella vaccine: a systematic review of current epidemiological evidence. Archives of Pediatric and Adolescent Medicine 157(7): 628-34.
56. World Health Organization. (2001). Recent concerns regarding MMR vaccine. Statement WHO/02: 25 January 2001. See: www.who.int/inf-pr-2001/ en/state2001-02.html (accessed 27 June 2006).